TNFα ablation, by contrast, prevents both inflammation and bone loss in TNFα transgenic mice [82], and pharmacological TNFα inhibitors, such as TNFα receptor decoy receptors, are effective agents for amelioration of rheumatoid arthritis in human patients [84, 211–214]. The gene discussed is TNF; the disease is rheumatoid arthritis.